Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research to test whether early detection of depression relapse can achieve 30% fewer full episodes

Research

The Brain Foundation Netherlands has allocated 300,000 euros for researchers, including Prof Catherine Harmer from Oxford University's Department of Psychiatry, to investigate whether existing smartphone Apps can lead to this reduction in risk.

In the United Kingdom, 1.24 million people suffer from depression annually. For a large proportion of these people, it is not the first time that they have a depressive episode. The relapse into depression is a major problem that occurs in 50 to 75% of people with previous depressive episodes. If depression returns it causes great suffering, loss of social roles, unproductiveness and high costs for society (estimated to be 7.5 billion pounds in the UK), in addition to risk of suicide and the risk of becoming a chronic depressive episode.

Read more (Department of Psychiatry website)

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.